Sleep more, protect your heart: new study tests circadian fix for teens with type 1 diabetes

NCT ID NCT06627504

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether improving sleep and circadian timing can reduce heart disease risk in adolescents with type 1 diabetes who typically sleep less than 7 hours per night. Fifty teens will follow a one-month program that includes a longer sleep schedule, a low dose of melatonin, reduced evening light, and morning bright light. Researchers will measure changes in insulin sensitivity, blood sugar control, and blood vessel function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
melatonin (500mcg) plus behavioral sleep schedule, light reduction, and morning bright light
What this could lead to
If successful, this could point toward a simple, non-drug way to improve heart health and blood sugar control in teens with type 1 diabetes.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The intervention combines several changes, making it hard to know which part works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.